Articles tagged with Cervical Cancer
Researchers found that zoledronic acid can halt the progression of cervical cancer in mice by inhibiting angiogenesis and matrix metalloprotease-9 expression. Additionally, a study on skin cancer revealed that Stat3 is required for initiation and promotion stages, suggesting it as a potential target for cancer therapy
Researchers found that zoledronic acid inhibits the growth of cervical cancer by targeting macrophages expressing matrix metalloproteinase-9 (MMP-9) and angiogenesis. This treatment approach offers new hope for cervical cancer patients.
A study found significant socioeconomic disparities in cervical cancer among American women, with higher poverty levels and lower education associated with increased incidence and mortality rates. Women from low-income census tracts were 20% more likely to be diagnosed with late-stage disease than those from high-poverty areas.
A study by Johns Hopkins Bloomberg School of Public Health found that Highly Active Antiretroviral Therapy (HAART) improved the regression rates of cervical squamous intraepithelial lesions (SIL) in HIV-positive women. However, a significant proportion of high-risk lesions persisted even among those who received HAART.
The UK national cervical screening programme has saved approximately 5,000 lives annually by reversing the rising trend in cervical cancer deaths among women under 35. The programme's success has also led to a significant reduction in costs, with a cost per life saved of less than £40,000.
A new HPV vaccine study is underway in women aged 24-45 to prevent cervical cancer and genital warts. The quadrivalent vaccine protects against four common strains of human papillomavirus virus, including two that cause cervical cancer and two that cause genital warts.
A recent study analyzed data from the Behavioral Risk Factor Surveillance System and found that millions of US women who have undergone a hysterectomy are being screened for cervical cancer unnecessarily. The study suggests that factors contributing to continued screenings include lack of awareness, physician enthusiasm for screening, ...
HIV-infected women are 3.9 times more likely to have HPV infection at the outset of the study, and smoking significantly increases this risk. Smoking and HIV infection may each alter the natural history of HPV infection to heighten tumor risk.
A survey of oncologists and nurses found that while most agree to offer trial results to patients, only 62% actually do so due to concerns over potential negative effects, patient interpretation, and resource consumption. Additionally, a new study demonstrates tamoxifen's association with reduced breast density, particularly in younger...
A new progesterone receptor antagonist may reduce tumor mass in patients with breast cancer, while a plant virus-based vaccine shows promise in preventing cervical and breast cancers. The novel vaccines aim to block the initial infection of HPV viruses that cause these cancers.
A meta-analysis of 15 studies found that HPV testing accurately identified high-grade cervical intraepithelial neoplasia (CIN2) or worse in 84.4% of women, while ruling out CIN2 or worse in 72.9%. HPV testing showed a sensitivity of 94.8% when using the Hybrid Capture II assay.
Two studies in the February 18 issue of JNCI investigated aspirin use and its association with two types of cancer. Regular aspirin use was found to lower Hodgkin's lymphoma risk, while patients with Barrett's esophagus may benefit from cost-effective aspirin therapy for esophageal cancer chemoprevention.
The HART study found HPV testing was more sensitive than cytology for detecting pre-malignant cells, but less specific. Surveillance at 12 months was as effective as immediate colposcopy for women with minimal abnormalities. This approach could improve detection rates of cervical cancer without increasing colposcopy referrals.
The article discusses a study on women's experiences with cervical cancer screening and finds that most are reluctant to reduce the frequency of Pap tests. Meanwhile, another study analyzes exercise stress test results for predicting cardiac mortality in older adults.
The partnership aims to address unequal burden of cancer on minority communities by providing access to clinical trials and strengthening cancer research programs. The collaboration will enhance cancer treatment capability and produce healthier outcomes for patients in South Central Los Angeles.
A new study reveals that residents of Appalachia experience a disproportionate increase in cancer incidence, particularly lung, colon, rectum, and cervix cancers. The study found that rural residents had even higher rates of these cancers compared to the general population.
Researchers analyzed 1.2 million screening result records, finding that extending Pap tests to 3-year intervals carries a small risk of 3-5 cancers per 100,000 people, similar to annual breast cancer incidence in men ages 45-64.
A new HPV vaccine targeting high-risk types could prevent up to 84% of cervical cancer cases. Testing a cocktail of these virus types could provide sufficient guidance for clinical decisions and future screening programmes.
Researchers debated changes to cervical cancer screening guidelines as a vaccine for human papillomavirus (HPV) showed promising results. The study found that vaccination combined with biennial screening was cost-effective and reduced cancer incidence and mortality.
Research suggests that cervical cancer vaccines may be less effective in women who are ovulating, due to fluctuations in antibody levels triggered by sex hormones. The study found higher antibody levels during the proliferative phase and lower levels around ovulation.
Researchers found no benefit to regular screenings for women without risk factors after a hysterectomy. The cost of screenings per year of life saved can be up to $12 million, highlighting the need for more targeted screening strategies.
A UK study found no overall increased risk of death among women who used oral contraceptives, suggesting a potential lower mortality rate compared to non-users. Smoking was associated with a higher risk of death from all causes, particularly in heavy smokers.
Researchers found that HPV16 is less associated with immune status than other HPV types, suggesting it can skirt the immune system. This discovery raises hypotheses about why cervical cancer rates are only moderately increased in HIV/AIDS-affected women.
Researchers found that women who used oral contraceptives for over 5 years were at a significantly higher risk of developing cervical cancer. The study analyzed data from 28 studies and found that the relative risk of cervical cancer increased with increasing duration of use, with risks doubling after 10 years.
A single-visit approach combining visual inspection with acetic acid wash (VIA) followed by cryotherapy shows promising results in rural Thailand, with 94% of women testing negative for VIA at one year's follow-up. The program is safe, acceptable, and feasible, achieving moderate population coverage with high satisfaction rates.
A study published in The Lancet found that same-day testing and treatment led to high rates of compliance with recommended treatment, with 83.2% returning for a follow-up visit. The 'one-stop' approach also improved patient satisfaction, with nearly 98% saying the treatment was equal to or better than expected.
A grading scale and simple visual analysis of 18F-FDG PET scans were used to predict cervical cancer patient outcomes, with high accuracy in survival prognoses. The test's reproducibility was demonstrated by independent observers' close scores and results.
A recent study found that women with negative Pap and HPV tests are at low risk for cervical intraepithelial neoplasia 3 or cancer, while those with a positive HPV test remain at risk. Researchers also discussed the challenges of analyzing DNA microarray data and recommended ways to improve its interpretation.
A study found that herpes simplex virus-2 (HSV-2) infection may increase the risk of invasive cervical cancer, particularly when combined with human papillomavirus (HPV) infection. The study analyzed data from seven countries and detected HSV-2 antibodies in nearly half of women with cervical cancer, but not in most women without the d...
Women with stage IIIb cervical cancer may benefit from different treatments depending on the spread of their disease, according to a new study. The research found that women whose cancer had not spread to lymph nodes had the highest survival rates, while those with upper chest lymph node involvement typically died within months.
A new computer model suggests that regular visual inspections every five years can save lives and reduce costs compared to DNA testing or traditional Pap smears. In Thailand, where cervical cancer is a major public health concern, this low-tech screening strategy could be an effective and affordable solution.
A study found that visual inspection with acetic acid (VIA) and HPV DNA testing are less expensive alternatives to traditional Pap smear screening for cervical cancer in developing countries. VIA, performed every 5 years in women ages 35-55, was the least expensive approach and saved the most lives.
Research highlights increased cervical cancer risk in smokers, while ovarian tumors with BRCA2 mutations also commonly have BRCA1 mutations. A potential therapeutic approach for eliminating malignant urothelial cells is also explored through CD40 ligation.
A study by Dr. G. Paolo Dotto and colleagues found that decreased Notch1 expression enables the increased expression of HPV viral proteins E6 and E7, promoting malignant cell transformation.
Researchers are studying the manatee virus to develop an approach to fighting cervical cancer in humans. The manatee immune system is being studied to gain a better understanding of diseases like HIV/AIDS.
The incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma declined sharply in the mid-1990s, mainly due to AIDS treatment improvements. However, non-AIDS-associated non-Hodgkin's lymphoma incidence has continued to rise.
HPV vaccination has shown high safety and efficacy, inducing high antibody titers against papillomaviruses. Hepatitis B vaccination is also highly effective in preventing chronic infection, with a 95% effectiveness rate in children.
Researchers found that abnormal E-cadherin presence in cervical lesions can prevent abnormal cells from being collected during testing. This could explain why four in 10 Pap smear results come back negative despite biopsy findings showing abnormalities.
Anal cancer is under-recognized, but rates of 350 cases per million in HIV-negative men and double in HIV-positive men indicate a need for prevention. Stanford researcher Mark Welton proposes an approach using yearly pap smears to detect precancerous cells before they develop into cancer.
The American Society for Colposcopy and Cervical Pathology has released comprehensive national consensus guidelines to evaluate women with abnormal Pap tests. The guidelines recommend utilizing new technologies, including liquid-based cytology and HPV testing, to standardize care.
A new study found that combining HPV and Pap tests for cervical cancer screening can detect an additional 225 cancers per 100,000 women, leading to a 59% decrease in mortality. The test is cost-effective and potentially life-saving, especially for women whose Pap test results are abnormal but inconclusive.
A randomized controlled trial found that culturally and linguistically suitable outreach and direct mail interventions increased Pap testing rates among Chinese-American women. The study suggests these interventions can help reduce racial and ethnic health disparities in cervical cancer screening.
The new Bethesda System aims to improve cervical cancer detection by providing more uniform, evidence-based care. Key changes include a new term for atypical cells at higher risk of precancer and clearer identification of benign cellular changes.
A study found that long-term use of oral contraceptives may increase the risk of cervical cancer in women who test positive for human papillomavirus (HPV) DNA. Women using oral contraceptives for 10 years or more were four times more likely to develop cervical cancer, highlighting the importance of HPV screening.
DIPEx, a website offering video, audio, and text interviews with patients, has launched its newest modules on breast cancer and bowel cancer. The site provides a unique resource for patients and healthcare professionals, aiming to improve communication and shared decision-making.
A recent large-scale study found a strong association between infection with human papillomavirus (HPV) and risk of vaginal cancer. Women with vaginal cancer were more likely to have been exposed to HPV-16, which causes genital warts.
A longitudinal study of 1791 Brazilian women found that persistent HPV infections increased the risk of squamous intraepithelial lesions (SIL) by 10.2 times compared to those without infection. Women with persistent type 16 or 18 HPV infections had a strong correlation with SIL incidence.
A large study of nearly 40,000 women in Denmark found that moderate drinkers became pregnant faster than non-drinkers. However, high alcohol intake was related to longer waiting times, particularly among older women and those who smoked or were overweight.
A systematic review of randomised trials found that women treated with combined chemotherapy and radiotherapy had an increased survival rate of 12% and reduced local and distant disease recurrence by around 40%. However, toxic side-effects were more common.
A study published in the Journal of Clinical Oncology found PET scans to be more accurate than CT scans in detecting cervical cancer spread. The imaging method reveals metabolic differences between cancer cells and normal tissue, identifying abnormal lymph nodes.
A recent study published in the American Journal of Epidemiology found a direct positive relationship between lifetime female sexual partners and the risk of prostate cancer in middle-aged men. Men with 30 or more partners had over twice the risk of developing prostate cancer compared to those with fewer partners.
A new test combining a vinegar solution with an HPV test accurately detects precancerous lesions and reduces false positives among African women, potentially saving thousands of lives. The test could be easily administered at home or in clinics, making it a game-changer for cervical cancer screening in developing countries.
A new study from UCSF found that postmenopausal women with normal Pap smear results may not need annual screening, as the benefits are small and the risk of false-positive testing is high. Researchers also discovered that hormone replacement therapy did not significantly affect cervical cellular abnormalities.
The UCSF Vietnamese Community Health Promotion Project has received a $3.6 million CDC grant to improve breast and cervical cancer screening among Vietnamese women in Santa Clara County. The project aims to address the high rate of cervical cancer in this population, which is five times that of Caucasian women.
A US study found that women with recent normal Pap smear results have a similar low rate of significant cellular abnormalities regardless of the time interval between screenings. The study suggests that some women may not need to be screened annually, and that less frequent screening may be safe for low-risk women.
Historical case of Eva Peron's secret surgery highlights the ongoing challenges of balancing medical care with social and political implications, according to Dr. Barron H. Lerner. Despite apparent openness in modern times, many confidential details remain hidden from public scrutiny.
A new study predicts that anal Pap smear screening every two to three years would detect pre-cancerous lesions among high-risk HIV-negative men and allow for early treatment of anal cancer. The analysis suggests that this simple procedure could save lives at a cost comparable to annual mammography.
The UK Markey Cancer Center will establish local coalitions and develop community outreach programs to address cancer barriers in Appalachian regions. The network aims to increase public awareness of clinical trials and promote participation among rural, medically underserved patients.
A self-collected test for human papilloma virus (HPV) is as sensitive as Pap smears in detecting cancerous and pre-cancerous lesions of the cervix. The test has shown promise in increasing cervical cancer screenings in both developed and developing worlds.
The Yale Cancer Center will conduct a clinical trial of a new compound, indole 3 carbinol, to suppress HPV infections and prevent cervical cancer. A $1.3 million grant from the NCI will fund the study in 200 participants with chronic HPV infections.